{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:52:28Z","timestamp":1778622748622,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/M011194\/1"],"award-info":[{"award-number":["BB\/M011194\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/M011194\/1"],"award-info":[{"award-number":["BB\/M011194\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["BB\/M011194\/1"],"award-info":[{"award-number":["BB\/M011194\/1"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["BB\/M011194\/1"],"award-info":[{"award-number":["BB\/M011194\/1"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Elucidating compound mechanism of action (MoA) is beneficial to drug discovery, but in practice often represents a significant challenge. Causal Reasoning approaches aim to address this situation by inferring dysregulated signalling proteins using transcriptomics data and biological networks; however, a comprehensive benchmarking of such approaches has not yet been reported. Here we benchmarked four causal reasoning algorithms (SigNet, CausalR, CausalR ScanR and CARNIVAL) with four networks (the smaller Omnipath network vs. 3 larger MetaBase\u2122 networks), using LINCS L1000 and CMap microarray data, and assessed to what extent each factor dictated the successful recovery of direct targets and compound-associated signalling pathways in a benchmark dataset comprising 269 compounds. We additionally examined impact on performance in terms of the functions and roles of protein targets and their connectivity bias in the prior knowledge networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      According to statistical analysis (negative binomial model), the combination of algorithm and network most significantly dictated the performance of causal reasoning algorithms, with the SigNet recovering the greatest number of\n                      <jats:italic>direct targets<\/jats:italic>\n                      . With respect to the recovery of\n                      <jats:italic>signalling pathways<\/jats:italic>\n                      , CARNIVAL with the Omnipath network was able to recover the most informative pathways containing compound targets, based on the Reactome pathway hierarchy. Additionally, CARNIVAL, SigNet and CausalR ScanR all outperformed baseline gene expression pathway enrichment results. We found no significant difference in performance between L1000 data or microarray data, even when limited to just 978 \u2018landmark\u2019 genes. Notably, all causal reasoning algorithms also outperformed pathway recovery based on input DEGs, despite these often being used for pathway enrichment. Causal reasoning methods performance was somewhat correlated with connectivity and biological role of the targets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, we conclude that causal reasoning performs well at recovering signalling proteins related to compound MoA upstream from gene expression changes by leveraging prior knowledge networks, and that the choice of network and algorithm has a profound impact on the performance of causal reasoning algorithms. Based on the analyses presented here this is true for both microarray-based gene expression data as well as those based on the L1000 platform.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-023-05277-1","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:03:40Z","timestamp":1681794220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Benchmarking causal reasoning algorithms for gene expression-based compound mechanism of action analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Layla","family":"Hosseini-Gerami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ixavier Alonzo","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Laing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Broughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"5277_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep40164","volume":"7","author":"M Iwata","year":"2017","unstructured":"Iwata M, Sawada R, Iwata H, Kotera M, Yamanishi Y. Elucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics. Sci Rep. 2017;7:1\u201315.","journal-title":"Sci Rep."},{"key":"5277_CR2","doi-asserted-by":"crossref","unstructured":"Mechanism matters. Nat Med. 2010;16:347\u20137.","DOI":"10.1038\/nm0410-347"},{"key":"5277_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/wsbm.114","volume":"3","author":"SI Berger","year":"2011","unstructured":"Berger SI, Iyengar R. Role of systems pharmacology in understanding drug adverse events. Wiley Interdiscip Rev Syst Biol Med. 2011;3:129\u201335.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"5277_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.4155\/tde.10.64","volume":"1","author":"J Watkins","year":"2010","unstructured":"Watkins J, Marsh A, Taylor PC, Singer DR. Personalized medicine: the impact on chemistry. Ther Deliv. 2010;1:651\u201365.","journal-title":"Ther Deliv"},{"key":"5277_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1021\/acs.oprd.0c00233","volume":"24","author":"C De Savi","year":"2020","unstructured":"De Savi C, Hughes DL, Kvaerno L. Quest for a COVID-19 cure by repurposing small-molecule drugs: mechanism of action, clinical development, synthesis at scale, and outlook for supply. Org Process Res Dev. 2020;24:940\u201376.","journal-title":"Org Process Res Dev"},{"key":"5277_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ddtec.2004.08.002","volume":"1","author":"PA Whittaker","year":"2004","unstructured":"Whittaker PA. The role of bioinformatics in target validation. Drug Discov Today Technol. 2004;1:125\u201333.","journal-title":"Drug Discov Today Technol"},{"key":"5277_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437\u20131452e17.","journal-title":"Cell"},{"key":"5277_CR8","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and Disease. Science. 2006;313:1929.","journal-title":"Science"},{"key":"5277_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1757-2215-4-21","volume":"4","author":"CA Sherman-Baust","year":"2011","unstructured":"Sherman-Baust CA, Becker KG, Wood WH III, Zhang Y, Morin PJ. Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. J Ovarian Res. 2011;4:21.","journal-title":"J Ovarian Res"},{"key":"5277_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/1471-2105-14-340","volume":"14","author":"NL Catlett","year":"2013","unstructured":"Catlett NL, Bargnesi AJ, Ungerer S, Seagaran T, Ladd W, Elliston KO, et al. Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data. BMC Bioinformatics. 2013;14:340.","journal-title":"BMC Bioinformatics"},{"key":"5277_CR11","doi-asserted-by":"crossref","unstructured":"Szalai B, Saez-Rodriguez J. Why do pathway methods work better than they should?. Syst Biol; 2020 ( Preprint).","DOI":"10.1101\/2020.07.30.228296"},{"key":"5277_CR12","doi-asserted-by":"publisher","first-page":"e27009","DOI":"10.1371\/journal.pone.0027009","volume":"6","author":"AE Enayetallah","year":"2011","unstructured":"Enayetallah AE, Ziemek D, Leininger MT, Randhawa R, Yang J, Manion TB, et al. Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platform. PLoS ONE. 2011;6:e27009.","journal-title":"PLoS ONE"},{"key":"5277_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/1471-2164-11-419","volume":"11","author":"R Kumar","year":"2010","unstructured":"Kumar R, Blakemore SJ, Ellis CE, Petricoin EF, Pratt D, Macoritto M, et al. Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693. BMC Genomics. 2010;11:419.","journal-title":"BMC Genomics"},{"key":"5277_CR14","doi-asserted-by":"publisher","first-page":"e1007403","DOI":"10.1371\/journal.pcbi.1007403","volume":"15","author":"A Hill","year":"2019","unstructured":"Hill A, Gleim S, Kiefer F, Sigoillot F, Loureiro J, Jenkins J, et al. Benchmarking network algorithms for contextualizing genes of interest. PLOS Comput Biol. 2019;15:e1007403.","journal-title":"PLOS Comput Biol"},{"key":"5277_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1177\/1087057114522690","volume":"19","author":"S Jaeger","year":"2014","unstructured":"Jaeger S, Min J, Nigsch F, Camargo M, Hutz J, Cornett A, et al. Causal network models for predicting compound targets and driving pathways in cancer. J Biomol Screen. 2014;19:791\u2013802.","journal-title":"J Biomol Screen"},{"key":"5277_CR16","doi-asserted-by":"publisher","first-page":"e1006651","DOI":"10.1371\/journal.pcbi.1006651","volume":"14","author":"NA Pabon","year":"2018","unstructured":"Pabon NA, Xia Y, Estabrooks SK, Ye Z, Herbrand AK, S\u00fc\u00df E, et al. Predicting protein targets for drug-like compounds using transcriptomics. PLoS Comput Biol. 2018;14:e1006651.","journal-title":"PLOS Comput Biol"},{"key":"5277_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.drudis.2014.12.014","volume":"20","author":"B Verbist","year":"2015","unstructured":"Verbist B, Klambauer G, Vervoort L, Talloen W, Shkedy Z, Thas O, et al. Using transcriptomics to guide lead optimization in drug discovery projects: lessons learned from the QSTAR project. Drug Discov Today. 2015;20:505\u201313.","journal-title":"Drug Discov Today"},{"key":"5277_CR18","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.2174\/1381612822666160224142812","volume":"22","author":"W Zhang","year":"2016","unstructured":"Zhang W, Bai Y, Wang Y, Xiao W. Polypharmacology in drug discovery: a review from systems pharmacology perspective. Curr Pharm Des. 2016;22:3171\u201381.","journal-title":"Curr Pharm Des"},{"key":"5277_CR19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1126\/science.1105891","volume":"309","author":"JM Raser","year":"2005","unstructured":"Raser JM, O\u2019Shea EK. Noise in gene expression: origins, consequences, and control. Science. 2005;309:2010\u20133.","journal-title":"Science"},{"key":"5277_CR20","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1073\/pnas.061034498","volume":"98","author":"T Ito","year":"2001","unstructured":"Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci. 2001;98:4569\u201374.","journal-title":"Proc Natl Acad Sci"},{"key":"5277_CR21","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1021\/acs.jcim.0c00864","volume":"61","author":"M-A Trapotsi","year":"2021","unstructured":"Trapotsi M-A, Mervin LH, Afzal AM, Sturm N, Engkvist O, Barrett IP, et al. Comparison of chemical structure and cell morphology information for multitask bioactivity predictions. J Chem Inf Model. 2021;61:1444\u201356.","journal-title":"J Chem Inf Model"},{"key":"5277_CR22","doi-asserted-by":"publisher","first-page":"e11036","DOI":"10.15252\/msb.202211036","volume":"18","author":"M Garrido-Rodriguez","year":"2022","unstructured":"Garrido-Rodriguez M, Zirngibl K, Ivanova O, Lobentanzer S, Saez-Rodriguez J. Integrating knowledge and omics to decipher mechanisms via large-scale models of signaling networks. Mol Syst Biol. 2022;18:e11036.","journal-title":"Mol Syst Biol"},{"key":"5277_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-019-0118-z","volume":"5","author":"A Liu","year":"2019","unstructured":"Liu A, Trairatphisan P, Gjerga E, Didangelos A, Barratt J, Saez-Rodriguez J. From expression footprints to causal pathways: contextualizing large signaling networks with CARNIVAL. Npj Syst Biol Appl. 2019;5:1\u201310.","journal-title":"Npj Syst Biol Appl"},{"issue":"Database issue","key":"5277_CR24","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012;40(Database issue):D1100-7.","journal-title":"Nucleic Acids Res."},{"key":"5277_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, et al. The drug repurposing hub: a next-generation drug library and information resource. Nat Med. 2017;23:405\u20138.","journal-title":"Nat Med"},{"key":"5277_CR26","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1093\/bioinformatics\/btx425","volume":"33","author":"G Bradley","year":"2017","unstructured":"Bradley G, Barrett SJ. CausalR: extracting mechanistic sense from genome scale data. Bioinformatics. 2017;33:3670\u20132.","journal-title":"Bioinformatics"},{"key":"5277_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cell.2015.05.056","volume":"162","author":"JH Woo","year":"2015","unstructured":"Woo JH, Shimoni Y, Yang WS, Subramaniam P, Iyer A, Nicoletti P, et al. Elucidating compound mechanism of action by network perturbation analysis. Cell. 2015;162:441\u201351.","journal-title":"Cell"},{"key":"5277_CR28","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/nar\/gkx1314","volume":"46","author":"H Noh","year":"2018","unstructured":"Noh H, Shoemaker JE, Gunawan R. Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza a viral infection. Nucleic Acids Res. 2018;46:e34.","journal-title":"Nucleic Acids Res"},{"key":"5277_CR29","doi-asserted-by":"publisher","DOI":"10.1039\/D1CB00069A","author":"M-A Trapotsi","year":"2021","unstructured":"Trapotsi M-A, Hosseini-Gerami L, Bender A. Computational analyses of mechanism of action (MoA): data, methods and integration. RSC Chem Biol. 2021. https:\/\/doi.org\/10.1039\/D1CB00069A.","journal-title":"RSC Chem Biol"},{"key":"5277_CR30","doi-asserted-by":"publisher","first-page":"e0201937","DOI":"10.1371\/journal.pone.0201937","volume":"13","author":"A Musa","year":"2018","unstructured":"Musa A, Tripathi S, Kandhavelu M, Dehmer M, Emmert-Streib F. Harnessing the biological complexity of Big Data from LINCS gene expression signatures. PLoS ONE. 2018;13:e0201937.","journal-title":"PLoS ONE"},{"key":"5277_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/psp4.12107","volume":"5","author":"L Cheng","year":"2016","unstructured":"Cheng L, Li L. Systematic quality control analysis of LINCS data: systematic quality control analysis of LINCS data. CPT Pharmacomet Syst Pharmacol. 2016;5:588\u201398.","journal-title":"CPT Pharmacomet Syst Pharmacol."},{"key":"5277_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fchem.2020.00296","volume":"8","author":"B Baillif","year":"2020","unstructured":"Baillif B, Wichard J, M\u00e9ndez-Lucio O, Rouqui\u00e9 D. Exploring the use of compound-induced transcriptomic data generated from cell lines to predict compound activity toward molecular targets. Front Chem. 2020;8:296.","journal-title":"Front Chem"},{"key":"5277_CR33","doi-asserted-by":"publisher","first-page":"e9923","DOI":"10.15252\/msb.20209923","volume":"17","author":"D T\u00fcrei","year":"2021","unstructured":"T\u00fcrei D, Valdeolivas A, Gul L, Palacio-Escat N, Klein M, Ivanova O, et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol Syst Biol. 2021;17:e9923.","journal-title":"Mol Syst Biol"},{"key":"5277_CR34","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie M, Jassal B, Stephan R, Milacic M, Rothfels K, Senff-Ribeiro A, et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 2022;50:D687\u201392.","journal-title":"Nucleic Acids Res"},{"key":"5277_CR35","unstructured":"Statistics\u2014Reactome Pathway Database. https:\/\/reactome.org\/about\/statistics. Accessed 13 June 2022."},{"key":"5277_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"5277_CR37","doi-asserted-by":"publisher","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","volume":"46","author":"DN Slenter","year":"2018","unstructured":"Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 2018;46:D661\u20137.","journal-title":"Nucleic Acids Res"},{"key":"5277_CR38","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3389\/fgene.2019.01203","volume":"10","author":"S Mubeen","year":"2019","unstructured":"Mubeen S, Hoyt CT, Gem\u00fcnd A, Hofmann-Apitius M, Fr\u00f6hlich H, Domingo-Fern\u00e1ndez D. The impact of pathway database choice on statistical enrichment analysis and predictive modeling. Front Genet. 2019;10:1203.","journal-title":"Front Genet."},{"key":"5277_CR39","doi-asserted-by":"crossref","unstructured":"Chowdhury S, Sarkar RR. Comparison of human cell signaling pathway databases-evolution, drawbacks and challenges.Database J Biol Databases Curation. 2015;2015.","DOI":"10.1093\/database\/bau126"},{"key":"5277_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12859-019-2863-9","volume":"20","author":"D Domingo-Fern\u00e1ndez","year":"2019","unstructured":"Domingo-Fern\u00e1ndez D, Mubeen S, Mar\u00edn-Lla\u00f3 J, Hoyt CT, Hofmann-Apitius M. PathMe: merging and exploring mechanistic pathway knowledge. BMC Bioinform. 2019;20:243.","journal-title":"BMC Bioinformatics"},{"key":"5277_CR41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"J Hughes","year":"2011","unstructured":"Hughes J, Rees S, Kalindjian S, Philpott K. Principles of early drug discovery. Br J Pharmacol. 2011;162:1239\u201349.","journal-title":"Br J Pharmacol"},{"key":"5277_CR42","unstructured":"clue.io. https:\/\/clue.io\/. Accessed 30 Aug 2019."},{"key":"5277_CR43","doi-asserted-by":"crossref","unstructured":"Garcia-Alonso L, Ibrahim MM, Turei D, Saez-Rodriguez J. Benchmark and integration of resources for the estimation of human transcription factor activities.bioRxiv. 2018;337915.","DOI":"10.1101\/337915"},{"key":"5277_CR44","doi-asserted-by":"publisher","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"P Badia-i-Mompel","year":"2022","unstructured":"Badia-i-Mompel P, V\u00e9lez Santiago J, Braunger J, Geiss C, Dimitrov D, M\u00fcller-Dott S, et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv. 2022;2:vbac016.","journal-title":"Bioinforma Adv"},{"key":"5277_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13059-020-1949-z","volume":"21","author":"CH Holland","year":"2020","unstructured":"Holland CH, Tanevski J, Perales-Pat\u00f3n J, Gleixner J, Kumar MP, Mereu E, et al. Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data. Genome Biol. 2020;21:36.","journal-title":"Genome Biol"},{"key":"5277_CR46","doi-asserted-by":"publisher","first-page":"eaba5933","DOI":"10.1126\/sciadv.aba5933","volume":"6","author":"AB Caldwell","year":"2020","unstructured":"Caldwell AB, Liu Q, Schroth GP, Galasko DR, Yuan SH, Wagner SL, et al. Dedifferentiation and neuronal repression define familial Alzheimer\u2019s disease. Sci Adv. 2020;6:eaba5933.","journal-title":"Sci Adv"},{"key":"5277_CR47","doi-asserted-by":"crossref","unstructured":"M\u00f8ller AF, Natarajan KN. Predicting gene regulatory networks from cell atlases. Life Sci Alliance. 2020;3(11):e202000658","DOI":"10.26508\/lsa.202000658"},{"key":"5277_CR48","doi-asserted-by":"publisher","first-page":"10010","DOI":"10.1093\/nar\/gkz805","volume":"47","author":"B Szalai","year":"2019","unstructured":"Szalai B, Subramanian V, Holland CH, Alf\u00f6ldi R, Pusk\u00e1s LG, Saez-Rodriguez J. Signatures of cell death and proliferation in perturbation transcriptomics data\u2014from confounding factor to effective prediction. Nucleic Acids Res. 2019;47:10010\u201326.","journal-title":"Nucleic Acids Res"},{"key":"5277_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C5MB00663E","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He Q-Y. ReactomePA: an R\/bioconductor package for reactome pathway analysis and visualization. Mol Biosyst. 2016;12:477\u20139.","journal-title":"Mol Biosyst"},{"key":"5277_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"5277_CR51","unstructured":"Neo4j Documentation. Neo4j Graph Database Platform. https:\/\/neo4j.com\/docs\/. Accessed 22 Sep 2020."},{"key":"5277_CR52","unstructured":"CRAN\u2014Package neo4r. https:\/\/cran.r-project.org\/web\/packages\/neo4r\/index.html. Accessed 22 Sep 2020."},{"key":"5277_CR53","volume-title":"Applied multivariate research: design and interpretation","author":"LS Meyers","year":"2013","unstructured":"Meyers LS, Gamst G, Guarino AJ. Applied multivariate research: design and interpretation. London: SAGE; 2013."},{"key":"5277_CR54","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cels.2018.03.001","volume":"6","author":"JK Huang","year":"2018","unstructured":"Huang JK, Carlin DE, Yu MK, Zhang W, Kreisberg JF, Tamayo P, et al. Systematic evaluation of molecular networks for discovery of disease genes. Cell Syst. 2018;6:484\u2013495e5.","journal-title":"Cell Syst"},{"key":"5277_CR55","doi-asserted-by":"publisher","first-page":"e1007276","DOI":"10.1371\/journal.pcbi.1007276","volume":"15","author":"S Picart-Armada","year":"2019","unstructured":"Picart-Armada S, Barrett SJ, Will\u00e9 DR, Perera-Lluna A, Gutteridge A, Dessailly BH. Benchmarking network propagation methods for disease gene identification. PLoS Comput Biol. 2019;15:e1007276.","journal-title":"PLOS Comput Biol"},{"key":"5277_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fgene.2015.00260","volume":"6","author":"MH Schaefer","year":"2015","unstructured":"Schaefer MH, Serrano L, Andrade-Navarro MA. Correcting for the study bias associated with protein\u2013protein interaction measurements reveals differences between protein degree distributions from different cancer types. Front Genet. 2015;6:260.","journal-title":"Front Genet."},{"key":"5277_CR57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ymeth.2012.06.003","volume":"57","author":"M Kotlyar","year":"2012","unstructured":"Kotlyar M, Fortney K, Jurisica I. Network-based characterization of drug-regulated genes, drug targets, and toxicity. Methods. 2012;57:499\u2013507.","journal-title":"Methods"},{"key":"5277_CR58","doi-asserted-by":"crossref","unstructured":"Sever R, Glass CK. Signaling by nuclear receptors. Cold Spring Harb Perspect Biol. 2013;5(3): a016709.","DOI":"10.1101\/cshperspect.a016709"},{"key":"5277_CR59","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0006-3223(00)01011-8","volume":"49","author":"JA Dani","year":"2001","unstructured":"Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry. 2001;49:166\u201374.","journal-title":"Biol Psychiatry"},{"key":"5277_CR60","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1172\/JCI129195","volume":"129","author":"K Stemmer","year":"2019","unstructured":"Stemmer K, M\u00fcller TD, DiMarchi RD, Pfluger PT, Tsch\u00f6p MH. CNS-targeting pharmacological interventions for the metabolic syndrome. J Clin Invest. 2019;129:4058\u201371.","journal-title":"J Clin Invest"},{"key":"5277_CR61","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13059-020-02100-5","volume":"21","author":"N Fortelny","year":"2020","unstructured":"Fortelny N, Bock C. Knowledge-primed neural networks enable biologically interpretable deep learning on single-cell sequencing data. Genome Biol. 2020;21:190.","journal-title":"Genome Biol"},{"key":"5277_CR62","doi-asserted-by":"publisher","first-page":"100147","DOI":"10.1016\/j.comtox.2020.100147","volume":"17","author":"A Aguayo-Orozco","year":"2021","unstructured":"Aguayo-Orozco A, Brunak S, Taboureau O. Extrapolation of drug induced liver injury responses from cancer cell lines using machine learning approaches. Comput Toxicol. 2021;17:100147.","journal-title":"Comput Toxicol"},{"key":"5277_CR63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1021\/acs.chemrestox.9b00288","volume":"33","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhu L, Thakkar S, Roberts R, Tong W. Can transcriptomic profiles from cancer cell lines be used for toxicity assessment? Chem Res Toxicol. 2020;33:271\u201380.","journal-title":"Chem Res Toxicol"},{"key":"5277_CR64","doi-asserted-by":"publisher","first-page":"17138","DOI":"10.1038\/s41598-021-96612-0","volume":"11","author":"G Lim","year":"2021","unstructured":"Lim G, Lim CJ, Lee JH, Lee BH, Ryu JY, Oh K-S. Identification of new target proteins of a Urotensin-II receptor antagonist using transcriptome-based drug repositioning approach. Sci Rep. 2021;11:17138.","journal-title":"Sci Rep"},{"key":"5277_CR65","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/toxsci\/kfp149","volume":"111","author":"T Hartung","year":"2009","unstructured":"Hartung T, Daston G. Are in vitro tests suitable for regulatory use? Toxicol Sci. 2009;111:233\u20137.","journal-title":"Toxicol Sci"},{"key":"5277_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/aivt.2016.0026","volume":"4","author":"T Hartung","year":"2018","unstructured":"Hartung T. Perspectives on in vitro to in vivo extrapolations. Appl Vitro Toxicol. 2018;4:305\u201316.","journal-title":"Appl Vitro Toxicol"},{"key":"5277_CR67","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41467-019-10148-6","volume":"10","author":"K Liu","year":"2019","unstructured":"Liu K, Newbury PA, Glicksberg BS, Zeng WZD, Paithankar S, Andrechek ER, et al. Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data. Nat Commun. 2019;10:2138.","journal-title":"Nat Commun"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05277-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-023-05277-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05277-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:18:30Z","timestamp":1729246710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-023-05277-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5277"],"URL":"https:\/\/doi.org\/10.1186\/s12859-023-05277-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1239049\/v1","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author David A. Collier was incorrectly assigned to the affiliation Ignota Labs, London, UK. The article has been updated to rectify the error.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CBDD and MetaBase\u2122 are proprietary to Clarivate\u2122, who granted a license to Eli Lilly and Company for access and use. A license can be obtained by visiting\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IAH, DAC, EL, DE and HB are either current employees or were employees of Eli Lilly and Company during the time the project took place. No competing interests are declared by LH-G or AB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}